| 前收市價 | 1.6000 |
| 開市 | 1.7000 |
| 買盤 | 1.4000 |
| 賣出價 | 1.8000 |
| 拍板 | 45.00 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 1.7000 - 1.8500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1.05k |
ZacksShould You Buy Legend Biotech (LEGN) Ahead of Earnings?
Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ZacksFDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line treatment.
- Zacks
Why Legend Biotech (LEGN) Stock Might be a Great Pick
Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
